There are obligations that companies should never ignore.
Not only the drug information laws, which are well known by the ISFs and drug companies, but are never implemented. There are also regulations of extreme interest such as those contained in the ethical-social balance sheet of companies. There are regulations relating to the safety of workers (in the case of the Isf, protection both in workplaces such as hospitals and on the road and inside the car); there are rules relating to the correct storage of medicines which must also be applied to free samples left in storage and in the premises of the ISF (we know very well that it causes many side effects from medicines, almost always attributed to the "drug" as a substance while they were samples, it was the poor conservation and the transport in the trunks of the cars, however prohibited by law).
Free samples are given to doctors so that they can distribute them to their patients for testing or experimentation, so they are drugs used as such.
Lastly, there is the failure to apply the law on the legal recognition of middle managers, which requires the placement of the ISF in the middle management area. Finally, there are many sentences of the Cassation which establish that the "agency contract for the ISF” (in the latter case we repeat that the doctor must prescribe the drugs according to “science and conscience” and therefore it is NOT acceptable for an ISF to be paid on the basis of turnover. This forces the ISF to do “everything” to be able to bring home any pay.)
The very nonchalant way in which the drug industry tackles the most basic problems of social justice would be incomprehensible if it did not count on the explicit complicity of the political and judicial power, including the co-interests with some professional categories.
From Giorgio Vitali
